Skip to main content

Advertisement

SpringerLink
Log in

The use of glucosamine therapy in osteoarthritis

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Glucosamine products have been used extensively for the management of pain in osteoarthritis. This paper reviews the most recent clinical and experimental studies regarding its efficacy and safety. Although clinical trials include methodologic flaws and publication bias, glucosamine is likely an effective therapy for the symptomatic management of osteoarthritis. In turn, definite proof for chondromodulating effect requires well-conducted clinical trials. In North America, glucosamine is an over-the-counter dietary supplement and preparations made by different manufacturers may vary. There is also a need to standardize this therapy and allow practitioners to give patients suitable advice. An ongoing long-term clinical trial in the US will possibly permit to investigate the clinical relevance of these results and give appropriate recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000, 43:1905–1915.

  2. Pendleton A, Arden N, Dougados M, et al.: EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000, 59:936–944.

    Article  PubMed  CAS  Google Scholar 

  3. Kelly GS: The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alt Med Rev 1998, 3:27–39.

    CAS  Google Scholar 

  4. van der Kraan PM, de Vries BJ, Vitters EL, et al.: Inhibition of glycosaminoglycan synthesis in anatomically intact rat patellar cartilage by paracetamol-induced serum sulfate depletion. Biochem Pharmacol 1988, 37:3683–3690.

    Article  PubMed  Google Scholar 

  5. van der Kraan PM, Vitters EL, de Vries BJ, van der Berg WB: High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability. J Orthop Res 1990, 8:565–571.

    Article  PubMed  Google Scholar 

  6. Setnikar I, Giachetti C, Zanolo G: Pharmacokinetics of glucosamine in the dog and in the man. Arzneimittelforschun 1863, 36:729–733.

    Google Scholar 

  7. Setnikar I, Palumbo R, Canali S, Zanolo G: Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993, 43:1109–1113.

    PubMed  CAS  Google Scholar 

  8. Setnikar I, Rovati LC: Absorption, distribution, metabolism and excretion of glucosamine sulphate: a review. Arzneimittelforschung 2001, 51:699–725.

    PubMed  CAS  Google Scholar 

  9. Adebowale A, Du J, Liang Z, Leslie JL, Eddington ND: The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Disp 2002, 23:217–225.

    Article  CAS  Google Scholar 

  10. Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F: High performance liquid chromatographic determination of glucosamine in rat plasma. J Pharm Pharm Sci 2002, 5:176–180.

    PubMed  CAS  Google Scholar 

  11. Barclay TS, Tsourounis C, McCart GM: Glucosamine. Ann Pharmacother 1998, 32:602–603.

    Article  Google Scholar 

  12. Largo R, Alvarez-Soria MA, Diez-Ortego I, et al.: Glucosamine inhibits IL-1beta-induced NF-kappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003, 11:290–298. Glucosamine inhibits the synthesis of proinflammatory mediators in human osteoarthritic chondrocytes.

    Article  PubMed  CAS  Google Scholar 

  13. Bassleer C, Rovati L, Franchimont P: Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998, 6:427–434.

    Article  PubMed  CAS  Google Scholar 

  14. Setnikar I, Cereda R, Pacini MA, Revel L: Antireactive properties of glucosamine sulfate. Arzneimittelforschung 1991, 41:157–161.

    PubMed  CAS  Google Scholar 

  15. Setnikar I, Pacini MA, Revel L: Anti-arthritic effects of glucosamine sulfate studied in animal models. Arzneimittelforschung 1991, 41:542–545.

    PubMed  CAS  Google Scholar 

  16. Sandy JD, Thompson V, Verscharen C: Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J 1998, 335:59–66.

    PubMed  CAS  Google Scholar 

  17. Shikhman AR, Kuhn K, Alaaeddine N, Lotz M: N-acetylglucosamine prevents in IL-beta-mediated activation of human chondrocytes. J Immunol 2001, 166:5155–5160.

    PubMed  CAS  Google Scholar 

  18. Oegema TR, Deloria LB, Sandy JD, Hart DA: Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits. Arthritis Rheum 2002, 46:2495–2503.

    Article  PubMed  CAS  Google Scholar 

  19. Noyszewski EA, Wroblewski K, Dodge GR, et al.: Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants. Arthritis Rheum 2001, 44:1089–1095.

    Article  PubMed  CAS  Google Scholar 

  20. Mroz PJ, Silbert JE: Effects of [3H]glucosamine concentration on [3H]chondroitin sulfate formation by cultured chondrocytes. Biochem J 2003, in press.

  21. Lippiello L: Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage 2003, 11:335–342. These observations suggest that, by enhancing the “protective” metabolic response of chondrocytes to stress, glucosamine and chodroitin sulfate may improve its ability for repair and regeneration.

    Article  PubMed  CAS  Google Scholar 

  22. Dodge GR, Jimenez SA: Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage 2003, 11:424–432. Glucosamine may have a beneficial effect in the prevention of articular cartilage loss in some patients with OA.

    Article  PubMed  CAS  Google Scholar 

  23. Tiku ML: Role of lipid oxidative stress in osteoarthritis: glucosamine inhibits advanced lipoxidation reaction and scavenges reactive carbonyl intermediates [abstract]. Ann Rheum Dis 2003, 62(suppl):S376.

    Article  Google Scholar 

  24. Towheed TE, Anastassiades TP, Shea B, et al.: Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001, 1:CD002946.

    PubMed  Google Scholar 

  25. Houpt JB, McMillan R, Wein C, Paget-Dellio SD: Effect of glucosamine hydrochloride in the treatment of pain osteoarthritis of the knee. J Rheumatol 1999, 26:2294–2297.

    Google Scholar 

  26. Chard JA, Tallon D, Dieppe PA: Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Ann Rheum Dis 2000, 59:414–418.

    Article  PubMed  CAS  Google Scholar 

  27. McAlindon TE, LaValley MP, Gulin JP, Felson DT: Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanalysis. JAMA 2000, 283:1469–1475.

    Article  PubMed  CAS  Google Scholar 

  28. Richy F, Bruyere O, Ethgen O, et al.: Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003, 163:1514–1522. This data-analysis suggests efficacy for glucosamine on joint space narrowing and Western Ontario and McMaster Universities Osteoarthritis Index.

    Article  PubMed  CAS  Google Scholar 

  29. Reginster JY, Deroisy R, Rovati LC, et al.: Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 2001, 357:251–256.

    Article  PubMed  CAS  Google Scholar 

  30. Pavelka K, Gatterova J, Olejarova M, et al.: Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002, 162:2113–2123.

    Article  PubMed  CAS  Google Scholar 

  31. Mazzuca SA, Brandt KD, Lane KA, Katz BP: Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees. Arthritis Rheum 2002, 46:1223–1227.

    Article  PubMed  Google Scholar 

  32. Hughes R, Carr A: A randomized, double-blind, placebocontrolled trial of glucosamine sulfate as an analgesic in osteoarthritis of the knee. Rheumatology 2002, 241:279–284. This pragmatic study does not show symptomatic effect of glucosamine sulfate.

    Article  Google Scholar 

  33. Rindone JP, Hiller D, Collacott E, et al.: Randomized controlled trial of glucosamine for treating osteoarthritis of the knee. Wes J Med 2000, 172:91–94.

    Article  CAS  Google Scholar 

  34. Cohen M, Wolfe R, Mai T, Lewis D: A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003, 30:523–528.

    PubMed  CAS  Google Scholar 

  35. Tapadinhas MJ, Rivera IC, Bignamini AA: Oral glucosamine sulfate in the management of arthrosis: report on a multicenter open investigation in Portugal. Pharmatherapeutica 1982, 3:157–168.

    PubMed  CAS  Google Scholar 

  36. Towheed TE: Current status of glucosamine therapy in osteoarthritis. Arthritis Rheum 2003, 49:601–604.

    Article  PubMed  Google Scholar 

  37. de Mattei M, Pellati A, Pasello M, et al.: High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthritis Cartilage 2002, 10:816–825.

    Article  PubMed  Google Scholar 

  38. National Institutes of Health web site. Accessible at http://www.nih.gov.

  39. Reginster JY, Bruyere O, Henrotin Y: New perspectives in the management of osteoarthritis structure modification: facts or fantasy? J Rheumatol 2003, 30(suppl):14–20.

    Google Scholar 

  40. Russell AS, Aghazadeh-Habashi A, Jamali F: Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 2002, 29:2407–2409.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology B Department, René Descartes University, AP-HP Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014, Paris, France

    Maxime Dougados MD

Authors
  1. Djamila Zerkak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maxime Dougados MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zerkak, D., Dougados, M. The use of glucosamine therapy in osteoarthritis. Current Science Inc 8, 507–511 (2004). https://doi.org/10.1007/s11916-004-0074-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-004-0074-0

Keywords

Search

Navigation